Hakutulokset - R.G. Taboada

Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors Tekijä G.R. de Almeida, R.P. Riechelmann, A.B. Brito, R.G. Taboada, A.L.M. da Silva, R.F. Weschenfelder, A.P.B.S. Etges

Hae kokoteksti